Mova Pharmaceuticals

Chennai, India
Pharmaceutical manufacturing and distribution of psychiatric, cardiovascular, and gynecological ranges in India.

About Mova Pharmaceuticals

Mova Pharmaceuticals is a Healthcare company based in Chennai (India). Pharmaceutical manufacturing and distribution of psychiatric, cardiovascular, and gynecological ranges in India. The company has 10 employees. Its Indian entity Mova Pharmaceuticals Private Limited reported revenue of β‚Ή3.88 Cr. Mova Pharmaceuticals offers products and services including Anti-psychotics and Cardiovascular Range. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medications and Nutraceuticals.

Company details

Mova Pharmaceuticals was established by Mr. Y. Jagan Mohan and his family members, building on his background in the pharmaceutical sector from 1977 to 1994. Various divisions such as PSY, COD, and GYNAEC are maintained, offering ranges including anti-psychotics, anti-parkinsons, cardiovascular drugs, and nutraceuticals. These products are distributed through multiple addresses in Chennai, with contact options provided for inquiries. The company is recognized for its pharmaceutical offerings in India, though specifics on operations are outlined in available details.

  • Headquarters Chennai, India
  • Employees 10
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Legal Name Mova Pharmaceuticals Private Limited
  • Date of Incorporation 28 Aug, 2006
  • Jurisdiction Chennai, Tamil Nadu, India
Key Metrics
  • Annual Revenue
    ₹3.88 Cr

    FY 2025 · -48% YoY

  • Net Loss
    -₹3.64 Cr

    FY 2025 · -94% margin

  • EBITDA
    -₹2.36 Cr

    FY 2025 · -61% margin

  • Employee Count
    10

Products & Services of Mova Pharmaceuticals

Mova Pharmaceuticals offers a comprehensive portfolio of products and services, including Anti-psychotics and Cardiovascular Range.

Anti-psychotics
Psychiatric Drugs

Anti-psychotics are manufactured for the treatment of mental health conditions and are part of the PSY division

Cardiovascular Range
Cardiac Medications

Cardiovascular drugs are provided for heart-related treatments and are included in the COD division

Board of directors of Mova Pharmaceuticals Private Limited (Mova Pharmaceuticals)

Mova Pharmaceuticals Private Limited is the primary company behind Mova Pharmaceuticals. The board of Mova Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Yelchuru Vikram, appointed in 2006. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Yelchuru Vikram
DIN 00613601
Whole-time director28 Aug 200620 yrs 2 moMova Pharmaceuticals Private Limited
Yelchuru Jaganmohan
DIN 00613563
Managing Director08 Dec 200619 yrs 10 moMova Pharmaceuticals Private Limited

Financials of Mova Pharmaceuticals

Figures of Mova Pharmaceuticals Private Limited, the primary company behind Mova Pharmaceuticals, for FY 2025. Revenue was ₹3.88 Cr (-48% year on year). Net loss was -₹3.64 Cr (-94% margin). EBITDA was -₹2.36 Cr (-61% margin). Revenue has grown at a compounded annual rate of -29% over three years and -22% over five years.

  • ₹3.88 CrRevenue · FY 2025 · -48% YoY
  • -₹3.64 CrNet loss · -94% margin
  • -₹2.36 CrEBITDA · -61% margin
  • ₹1.90 CrPaid-up capital
  • 10Employees (provident fund records)
  • -29%Revenue CAGR, 3 years
  • -22%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Mova Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Mova Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Mova Pharmaceuticals

Mova Pharmaceuticals is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

Mova Pharmaceuticals has 10 employees.

The primary company behind Mova Pharmaceuticals, Mova Pharmaceuticals Private Limited, reported revenue of β‚Ή3.88 Cr for FY 2025, down 48% year on year.

Mova Pharmaceuticals was established by Mr. Y. Jagan Mohan and his family members, building on his background in the pharmaceutical sector from 1977 to 1994. Various divisions such as PSY, COD, and GYNAEC are maintained, offering ranges including anti-psychotics, anti-parkinsons, cardiovascular drugs, and nutraceuticals. These products are distributed through multiple addresses in Chennai, with contact options provided for inquiries. The company is recognized for its pharmaceutical offerings in India, though specifics on operations are outlined in available details.

Mova Pharmaceuticals offers Anti-psychotics and Cardiovascular Range.

Mova Pharmaceuticals operates through Mova Pharmaceuticals Private Limited.

The legal entities of Mova Pharmaceuticals currently have 2 directors, including Yelchuru Vikram, Yelchuru Jaganmohan.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available